Skip to main content

Elkins David V's Form 4 filing

Bristol Myers Squibb CoBMY · filed Sep 3, 2025

Accession no.
0000014272-25-000144
Filed
Sep 3, 2025
Trade date
Sep 2, 2025
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $2.65M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Elkins David VCIK 0001451604Officer (EVP, Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 2, 2025Common Stock, $0.10 par valueSSaleDisposed−56,000$47.33F2−$2,650,480167,379Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $47.075 to $47.820, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Remarks

EXHIBIT LIST: EX-24 Exhibit 24 - David V. Elkins, GRAPHIC Exhibit 24 - David V. Elkins

Read the full filing on SEC EDGAR (opens in a new tab)